Medicines review services for BAME communities
Research type
Research Study
Full title
Improving the accessibility of medicines review services in primary care for people from BAME communities: a qualitative investigation and co-design process.
IRAS ID
295115
Contact name
Andy Husband
Contact email
Sponsor organisation
Newcastle University
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 6 months, 1 days
Research summary
This project is designed to explore how patients who are of ethnicities reflective of Black, Asian and Minority Ethnic (BAME) backgrounds engage with the process of regular medicines review. Our intention is to run interviews and co-design workshops to collect patient perspectives and gain insight into the accessibility of these reviews for patients from BAME communities. From the data collected, this research aims to produce a co-designed intervention to better support patients from these groups, increase their engagement with services, and work to establish safe and effective medicines use.
Understanding the experiences of patients from BAME communities is vital and timely. This patient cohort has been recognised as an under-represented group in health and social care research. Gaining a better understanding of the extent to which they engage with medicines review and their perceived barriers and enablers to engaging with the process, will influence the review processes going forward.
The project will take place in the West End of Newcastle, in three general practice surgeries situated in an area of wide ethnic diversity. We will ensure the views and experiences of different BAME communities living in the area are represented. We will also use contacts from Connected Voice HAREF (Project Health Equalities for BAME Communities) to bring people into the project from asylum backgrounds, particularly those with failed asylum applications who are still in receipt of regular medicines.
The study will run for 6-months, from March-September 2021.
Participant involvement will be in one of the following ways:
Phase 1: a semi-structured interview and/or
Phase 2: a co-design workshop.Given the COVID-19 pandemic, the researchers anticipate that the interviews and workshops will be facilitated remotely, using telephone calls or video-call based software (e.g. Zoom). However, if/when it becomes safe to do so, COVID safe face-to-face interviews may be also be an option.
REC name
London - Bromley Research Ethics Committee
REC reference
21/HRA/1426
Date of REC Opinion
8 Jun 2021
REC opinion
Further Information Favourable Opinion